FDA Warns About Dangerous Side Effect of AML Drug Enasidenib FDA Warns About Dangerous Side Effect of AML Drug Enasidenib

A life-threatening side effect called differentiation syndrome is not being recognized in patients receiving the acute myeloid leukemia drug enasidenib, says the FDA.News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news